Built AI-native
We drive an efficient AI-native operating business model spanning development, regulatory, and commercial functions.
About
Proven therapeutics · a highly efficient agentic operating model · built to commercialize at the scale of ‘big pharma’.
Skythia Therapeutics is an AI-native biopharmaceutical company built to commercialize proven therapeutics with a fraction of the headcount the industry assumes is required.
We embed agentic AI across development, regulatory, and commercial operations — not as a feature, but as the operating model — turning proven medicines into accessible treatments faster and leaner than legacy pharma.
Our focus is underserved areas where medical need is high and accessible care can meaningfully improve lives.
The competitive edge
Skythia uses AI to bring therapies to patients faster.
A purpose-built, agentic AI infrastructure runs the work of a full commercial organization — compressing cost and timelines so more patients reach effective treatment, sooner. The result is a new kind of biopharma: small, fast, and full-stack.
Purpose-driven
We seek to make a difference to the failed pharma model.
Aligned team
We are a dedicated team of experienced biopharma executives.
Focus
Focused on underserved areas where medical need is high.
Skythia works on advancing a portfolio of differentiated treatment options where medical need is high and accessible care can meaningfully improve lives.
To redefine medical care for these underserved areas, we use agentic AI models to make meaningful therapeutic options more accessible, practical, and impactful.
Mission
At Skythia Therapeutics, we aim to bring novel treatment options to people who need medicines for a healthier life.
Get in touch
Partner with us.
For partnership, pipeline, and investor inquiries, reach the team directly.
partners@skythia.bio